Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
Effects of Shiga toxin 2, a cytotoxic protein causing hemolytic-uremic syndrome (HUS), were studied in a 3D model of renal cortical epithelial cells (DesRochers et al
Rigault, C., Mazue, F., Bernard, A., Demarquoy, J
It is estimated that approximately 10 percent of the United States adult population- which is over 25 million Americans experience some form of tinnitus according to The National Institute on Deafness and Other Communication Disorders (NIDCD)
The most frequently reported adverse effects involve gastrointestinal symptoms, which typically emerge during the initial days to weeks of supplementation as the gut microbiome adjusts to the introduced bacterial strains